• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of and finding treatments for complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia (FM), long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Suggestions and Questions for Dr Ron Davis

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
Hi everyone,

It occurred to me that with all the knowledge on this board, we might put together a thread with suggestions and questions for Dr Davis.

@Rose49 has indicated that he's interested in our ideas, so this could be a good opportunity to collate hypotheses, questions, and personal experiences in an organized way and directly help with Dr Davis' research

Edit:

Tagging some people whose posts I benefit from that might be interested:

@Hip
@eljefe19
@nandixon @halcyon @alex3619
 
Last edited:

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
I'll start...

- Will your electronic testing assay be able to assess whether something upstream / beyond the serum is the producing the problem?

E.g. something like a virus, malfunctioning lymph, or epigetically altered organ

- Will you be testing Dr Jay Goldstein's "rapid remission" drugs such as ketamine and lidocaine on the serum?

See this link for more Dr Goldstein drugs

See this thread with a diagram (third post down) of Dr Goldstein's protocol

- Does your research encompass potential causal factors such as dysfunction of the ANS / brain, or ongoing environmental poisoning (be it from myotoxins or synthetic chemicals)?
 
Last edited:

ScottTriGuy

Stop the harm. Start the research and treatment.
Messages
1,402
Location
Toronto, Canada
How, if at all, does De Vega's epigenetic research dovetail with your findings?

Our results indicate DNA methylation modifications in cellular metabolism in ME/CFS despite a heterogeneous patient population, implicating these processes in immune and HPA axis dysfunction in ME/CFS. Modifications to epigenetic loci associated with differences in glucocorticoid sensitivity may be important as biomarkers for future clinical testing. Overall, these findings align with recent ME/CFS work that point towards impairment in cellular energy production in this patient population."

https://bmcmedgenomics.biomedcentral.com/articles/10.1186/s12920-017-0248-3
 

Helen

Senior Member
Messages
2,243
- Did you get any results from the analyzes with the new method that, according to Ian Lipkin, should detect any possible microbe and ongoing infection? In other words, are the patients having infections compared to the controls, or not?

- Do you have a hypothesis how comes that Whitney as well as many PWME had a severe vitamin B2 deficiency? I don´t know if it was about a riboflavin deficiency or the converted, bio-active form of B2.
 

eljefe19

Senior Member
Messages
483
Jesse I don't know if anyone you tagged got a notification because I didn't.
I think nandixon has been good at contacting Prof Davis with any new theories regarding mTOR.

I'm curious what he thinks of Dr. Chia's work, and if he think enteroviruses could cause the metabolic issues found in Naviaux/F&M.
 

eljefe19

Senior Member
Messages
483
Here Jesse;

Hi everyone,

It occurred to me that with all the knowledge on this board, we might put together a thread with suggestions and questions for Dr Davis.

@@Rose49 has indicated that he's interested in our ideas, so this could be a good opportunity to collate hypotheses, questions, and personal experiences in an organized way and directly help with Dr Davis' research

@Hip
@nandixon @halcyon @alex3619
 

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
@AshleyHalcyoneH and @Rose49 asked us to send them questions to an e-mail address.

http://forums.phoenixrising.me/inde...ch-with-ronald-w-davis-phd.49408/#post-815258

http://forums.phoenixrising.me/inde...ch-with-ronald-w-davis-phd.49408/#post-815272

I think it might be a bit difficult for them to hunt down questions all over the forum.

Fair point, we should all submit our questions via email as well. But I also think there's value in publically sharing them so we can build on each other
 

eljefe19

Senior Member
Messages
483
Alright Jesse, in the interest of building on each other, my question is this.

Question; Is Prof Davis aware that certain viruses can inhibit Akt/mTOR?
A quick google search of "Coxsackievirus B mTOR" revealed a couple of sources about Coxsackievirus A16 inhibiting Akt/mTOR (Here and here).

That first source says the following;
By contrast, there are a number of viruses that suppress Akt activation...Inhibition of Akt phosphorylation by Coxsackievirus A16 (CA16) contributes to the upregulation of autophagy, which enhances viral replication

Coxsackievirus B has some evidence of causing ME/CFS whereas I don't believe there is any links with Coxsackie A, yet. My doctor tested for both, and my Coxsackievirus A titers (including A16) were way more elevated than CVB.

Question; If CVA16 can inhibit Akt/mTOR, can it be surmised that CVA16 can cause ME/CFS?
 

eljefe19

Senior Member
Messages
483
Here's some more circumstantial evidence for Coxsackievirus causing ME/CFS.

https://www.ncbi.nlm.nih.gov/pubmed/25755782
IL-10-producing B cells are increased in CVB3-induced AVMC, indicating that IL-10-producing B cells may play an important role in the pathogenesis of CVB3-induced AVMC

So we've got this study here, that relates CVB3 infection to IL-10 producing B cells. Perhaps this is the B cell mediated feedback loop discussed in the mTOR thread, at least for a subset of patients.

Hypothesis;
CVB3 (and other enteroviruses) can cause ME/CFS by increasing IL-10 producing B cells which enable the virus to remain chronically activated while it simultaneously inhibits Akt/mTOR. Therefore, Rituximab cures those with IL-10 producing B cell dependent enterovirus infections causing Akt/mTOR inhibition and ME/CFS.
According to this source, CVB3 induces a direct cytopathic effect (CPE) and apoptosis on infected cells (bad). Treatment with Rapamycin (a strong mTOR inhibitor) made the CPE and Apoptosis worse, indicating that mTOR plays a role in the pathogenesis of the CVB3 virus.

Taken together, these data illustrate a new and imperative role for PI3K/AKT/mTOR signaling in CVB3 infection in HeLa cells and suggest an useful approach for the therapy of CVB3 infection

Another source; https://www.ncbi.nlm.nih.gov/pubmed/23406864
CVB3 can down-regulate the expressions of mTOR and p70S6K mRNA. The mTOR expression in the starvation serum is higher than that in the conventional culture.
 

eljefe19

Senior Member
Messages
483
BUMP...

Because I believe this is really good idea for a thread. It's the perfect place to generate, and coordinate, our communication to Ron Davis.

Does anyone have any opinions on the research I found last night???
It seems Coxsackievirus of several types can inhibit Akt/mTOR and induce autophagy instead. @nandixon has the potential domino effect causing ME/CFS narrowed down to these two options. See below;


IMG_2660.PNG


So if we go with option two, why could the initial cause, which is currently '????' not be a chronic enterovirus infection?
It directly causes the next step in the domino effect....

Furthermore, CVB3 (Reference) has been found to evade the bodies' normal defenses by an IL-10 B-cell dependent mechanism (possible Rituximab connection?).

I presented evidence that both CVA16 and CVB3 can disturb Akt/mTOR signaling, above.

I believe that Prof Davis should prioritize drugs for his new device that have antiviral action against certain enteroviruses, such as CVA/CVB/Echovirus/EV71. I can produce a list of these with a little help from @Hip 's great antiviral post. I'll edit in later.
 

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
BUMP...

Because I believe this is really good idea for a thread. It's the perfect place to generate, and coordinate, our communication to Ron Davis.

Does anyone have any opinions on the research I found last night???
It seems Coxsackievirus of several types can inhibit Akt/mTOR and induce autophagy instead. @nandixon has the potential domino effect causing ME/CFS narrowed down to these two options. See below;


View attachment 20033

So if we go with option two, why could the initial cause, which is currently '????' not be a chronic enterovirus infection?
It directly causes the next step in the domino effect....

Furthermore, CVB3 (Reference) has been found to evade the bodies' normal defenses by an IL-10 B-cell dependent mechanism (possible Rituximab connection?).

I presented evidence that both CVA16 and CVB3 can disturb Akt/mTOR signaling, above.

I believe that Prof Davis should prioritize drugs for his new device that have antiviral action against certain enteroviruses, such as CVA/CVB/Echovirus/EV71. I can produce a list of these with a little help from @Hip 's great antiviral post. I'll edit in later.

I like this, but how to explain those with no evidence of enteroviruses? Different subgroup?
 

eljefe19

Senior Member
Messages
483
I thought of another couple.

QUESTION: Shouldn't Prof Davis test things like Leucine (a pure mTOR activator and direct AMPK inhibitor) and other known activators that aren't FDA approved drugs?

He tested Pyruvate and ATP so I don't see why not. Leucine, NAC, various aminos, Insulin, Myostatin inhibitor Myo-X, Follistatin, growth factors etc.

QUESTION: Would something like Rituximab, which takes months to exert clinical benefit on average, work to stop impedance in Ron's device?

I suppose I will email some of these to Ron and Janet, but do you guys have any feedback first???
 
Messages
2,087
I thought of another couple.

QUESTION: Shouldn't Prof Davis test things like Leucine (a pure mTOR activator and direct AMPK inhibitor) and other known activators that aren't FDA approved drugs?

He tested Pyruvate and ATP so I don't see why not. Leucine, NAC, various aminos, Insulin, Myostatin inhibitor Myo-X, Follistatin, growth factors etc.

QUESTION: Would something like Rituximab, which takes months to exert clinical benefit on average, work to stop impedance in Ron's device?

I suppose I will email some of these to Ron and Janet, but do you guys have any feedback first???

Did you watch the latest video's, AFAIK he will test everything he can in vitro.
 

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
- When you find a drug that works in vitro, what's the plan to test in patients?

- Will you be testing non pharmaceutical treatments on the serum such as IVIG, ozone and plasmapheresis or non FDA approved drugs like DRACO, Plecenoril and Ampligen?

- Would you be willing to make public a running list of tested drugs (with results) and a list of drugs in the queue?
 

Jesse2233

Senior Member
Messages
1,942
Location
Southern California
- Will Ron be testing unorthodox treatments like bee venom on the serum?

- Are serum samples separated by demographic factors (genetics), illness severity, duration of illness, and probable cause of onset (viral, mold, gradual)? And if so, will all drugs be tested on all samples subsets?